United states researchers believe that ginkgo improves memory in some patients with alzheimer's and cognitive dysfunction, suggesting that it increases blood flow to the brain and may combat vascular eye disease. Federation to implement the youth component also includes the National AIDS Center and the NGOs Tanadgoma, Bemoni, and International Network of Youth Organizations' Juvenko. Wide-scale cultural, educational, and peer interventions are planned by the consortium within the GFATM project, with the involvement of Georgian teen pop and sports celebrities. Events include things like `Safe Vacations' during the summer at the Black Sea coast and during the winter at skiing vacation sites, the `Gudauri' and `Bakuriani' music festivals, `Crystal Eve, ' a music bus caravan, `Georgian youth against AIDS, ' a marathon concert on December, which is World AIDS Day, at the Tbilisi Opera House, exhibitions of posters on HIV AIDS, a movie festival and much more. The main strategy of the intervention is the high involvement and participation of youth themselves in all activities and events.
Consecutive, nonhypertensive patients who developed focal brain ischemia without a change in their blood pressure and who were evaluated by one of the authors within four hours of onset were treated with a vasopressor drug infusion. The blood pressure was raised to 150 to 170 85 to 100 mm Hg for at least three hours. The infusion was discontinued if no improvement in brain function occurred. If neurological improvement did not occur after 30 minutes of vasopressor drug therapy, the patients were also treated with lowmolecular-weight dextran 500 ml over a threehour period, then 500 ml every 12 hours ; and dexamethasone 6 mg every six hours ; . If brain function had improved during vasopressor treatment, the vasopressor drug infusion was then slowed in order to allow a decrease in the blood pressure. The blood pressure needed for preservation of brain function was then determined by repeatedly raising the blood pressure and allowing it to fall. Hyperosmotic glucose and mannitol, low-molecular-weight dextran, aminophylline, and dexamethasone were given to one patient who had improved with vasopressor drug treatment to see if these agents would lower the blood pressure level needed for preservation of brain function during the first few. World Baht and Moy, 1997; WHO, 1993 ; , and the possible contribution from medicinal herbs might be significant. For instance, renal dysfunction would be expected in sensitive population groups at cadmium exposure levels half of the present PTWI Nordberg, 1999 ; . 4.2. Mercury The highest concentration of mercury, as total mercury, found in this study, 0.09 mg g in ginkgo biloba Table 2 ; , is much lower than the limit of 0.5 mg Hg g recommended in drugs, including from plants, in Singapore Chow et al., 1995 ; . Vega-Carrillo et al. 1997 ; found mercury at similar levels 0.01 to 0.08 mg g ; in 30 plants used in traditional medicine in Mexico and mercury was not detected 0.001 mg g ; in 21 samples of ginseng products capsule and tincture ; in another study Khan et al., 2001 ; . The higher estimated weekly intake of mercury 0.70 mg person ; was found for the only ginseng sample with detectable residues, and is insignificant when compared with the PTWI of 5 mg kg body weight for total mercury JECFA, 2000 ; , or 300 mg person. Mercury exposure for the general population occurs mainly from consumption of fish, as methyl mercury Baht and Moy, 1997; Barbosa, 1997 ; and possibly from dental amalgam fillings WHO, 2003 ; , and it is unlikely that the exposure through medicinal herbs will affect human health. 4.3. Lead Lead was detected only in samples prepared with the leaves, fruits or barks of the plants cascara buckthorn, horse chestnut, centella asiatic, celastraceae and ginkgo biloba ; , what agrees with the fact that lead in plants is due mainly to aerial deposition or absorption by their.

The oral cavity often is the site of undesirable side effects from cancer therapy that adversely affect patients' quality of life, ability to tolerate therapy, and overall cost of treatment. Stomatotoxicity which leads to disruption of the integrity of the oral mucosa frequently results in the mouth serving as a source for systemic or distant infection. Unfortunately, oral complications of cancer therapy are common; virtually all patients being treated for head and neck tumors develop local side effects. From a quantitative standpoint, even more important is the finding that approximately 40% of patients being treated for other cancers develop mouth problems as a consequence of treatment.1 The symptomatic and functional consequences of oral complications of cancer treatment result in increased lengths of hospital stays, use of analgesics and antibiotics, need for nursing services, and adjunctive care such as parenteral feeding. For example, an analysis of autologous bone marrow transplant recipients demonstrated that patients with mucositis had hospital stays which were 5 days longer compared with patients without the condition.2 In the past, oral complications of therapy frequently were considered to be inevitable, often were not recognized early, and were treated retrospectively rather than in a prospective or preventive manner. Fortunately, a more scientifically based approach to the analysis of oral complications has produced much information relative to the prospective determination of risk, intervention techniques, differential diagnosis of hard- and soft-tissue changes, and appropriate therapies.3 PRETREATMENT ASSESSMENT Many side effects of cancer therapy can be completely prevented or eliminated if intervention occurs before the onset of treatment with drugs or radiation.46 Thus, a protocol that includes pretreatment oral assessment is recommended. The objectives of such evaluation for patients about to undergo myelosuppressive therapy include the identification and elimination of asymptomatic oral infections, potential oral infections, and both sources and sites of chronic irritation. These goals also apply to the patient about to undergo head and neck irradiation, who also requires presurgical assessment for prosthetic rehabilitation and the initiation of regimens to prevent or minimize radiation-induced caries, xerostomia, and the risk of osteoradionecrosis ORN ; . EFFECTIVENESS OF SCREENING Woods and colleagues7 found that 72% of patients screened before bone marrow transplantion demonstrated positive findings relative to latent infection, irritating prostheses, or restorations of the oral mucosa. Results of another study in the same population suggested that a third of patients required oral care before their transplantation surgery.8 Lockhart and Clark reported that 97% of patients about to undergo treatment for cancers of the head and neck needed some dental care.9 Studies by Greenberg and colleagues10 as well as Sonis and colleagues6 further demonstrated that prechemotherapy intervention for abnormalities found on screening had a significant, favorable impact on morbidity, especially that related to local infection and sepsis. Cost savings also may be achieved by eliminating oral sources of sepsis before the initiation of therapy. For example, data suggest that successful screening of partially erupted third molars i.e., wisdom teeth ; in patients with leukemia results in a savings of over 0, 000 per 100 patients, because 60% would otherwise develop sepsis requiring hospitalization.11 This potential saving may increase as other findings are revealed by the screening. TIMING OF ASSESSMENT If oral screening is performed so close to the initiation of cancer therapy as to preclude dental intervention, the value of the process is nullified. The ideal interval between the completion of dental treatment, particularly extraction, and the initiation of radiation therapy has been debated in the literature.12 Nonetheless, it appears that a minimum of 2 weeks, and preferably 3 weeks, is desirable. For patients about to undergo chemotherapy, sufficient time and glycopyrrolate.

FIRST GAZETTE NOTICES -CONTINUED. IC MARINE SURVEYORS LIMITED ICM EUROPE LIMITED ICON FINANCE LIMITED ICONIC CONTRACTS LIMITED ICONIC SERVICES LIMITED ICT CONTRADING LTD. IDATAKIT LIMITED I.D.B. LTD IDEAHAUS LIMITED IDEAS FIRST LIMITED THE IDENTITY PROJECT IDEOLOGICS LIMITED IDLECOTE LTD I.D. PRODUCT DEVELOPMENT LIMITED I E PLACEMENTS UK ; LIMITED IFS CONSULTING LIMITED IGA BUILDING CONTRACTORS LTD IGNITE THE NET LIMITED IG1 BROTHERS LIMITED IG TRADING LIMITED IJON LIMITED ILLUME RECRUITMENT LIMITED IMAC COOLING EQUIPMENT LIMITED IMAGE PERFECT LIMITED IMAGES HAIR AND BEAUTY LIMITED IMAGETABLE LIMITED IMAGE TELEVISION LIMITED IMBERCLAY LTD IMBERLAY LTD I'MMATERIAL LTD IMMEDIATE CONNECTIONS LTD IMPERIAL SECURITIES LIMITED IMPERIAL TILES AND BATHROOMS LIMITED IMS TRUSTEES UK ; LTD. INDALO COMPUTER CONSULTANTS LIMITED INDEPENDANT PRINT LIMITED INDEPENDENT AGGREGATE SOLUTIONS LIMITED INDEPENDENT CONSTRUCTION CONSULTANTS LIMITED THE INDEPENDENT STAKEHOLDER COMPANY LIMITED INDEX TRANSPORT LIMITED INDICIUM EUROPE LIMITED INDIGO SKIES LIMITED INDIVIDUAL CARE LIMITED INDIVIDUAL PROTECTION SYSTEMS IPS ; LIMITED INDUSTRIAL PLANT SALES LIMITED INDUSTRIAL TRADE&TOURISM IT&T ; LIMITED INES PROTECTION LIMITED INFIN-IT SOFTWARE LIMITED INFINITY BUSINESS SY ; LIMITED INFINITY FINANCE LIMITED INFIVEPARTS LIMITED INFOCUTED SERVICES LIMITED INFO DISPLAY SERVICES LIMITED 05201463 05363592 04626863 INFOFORYOU LTD INFONEXUS LTD INGELOSI INVESTMENT SERVICES LIMITED INGLEBY 1655 ; LIMITED INHOUSE FASHIONS LIMITED INI PROJECTS LIMITED INITIAL SECURITIES LIMITED INKTAB SERVICES LIMITED IN-MOTION SOLUTIONS LIMITED INN-HOUSE SECURITY LIMITED INNOVATE RACING LTD INNOVATION NETWORK UK LIMITED INNOVATIVE ELECTRICAL PRODUCTS LTD INNOVATIVE PRIME MOVERS LIMITED INNOV TIVE LIMITED INNTERIM LIMITED INOVA PRODUCTS LIMITED INSANITORIUM PROMOTIONS LIMITED INSHAPE BODY TONING ; LIMITED INSIDE SECRETS LIMITED INSIGHT CONSULTANTS LIMITED INSPIRED ASPIRATIONS LIMITED INSPIRED CREDIT SOLUTIONS LTD INSTALLATIONS INCORPORATED LIMITED INSTALTECH LIMITED INSTANT PROFESSIONAL DEVELOPMENT LIMITED THE INSTITUTE OF SERVICE INDUSTRIES MANAGERS AND EXECUTIVES LIMITED INTA-FLOORING LIMITED INTASYS ONLINE LIMITED INTEGRAL GROUP HOLDINGS LTD INTEGRAL HCE LTD INTEGRAL LEARNING LIMITED INTEGRATED CLEANING SOLUTIONS LTD INTEGRATED PAYMENT SOLUTIONS LIMITED INTELL BUSINESS SYSTEMS LIMITED INTELLECT TOUCHONE LIMITED INTELLIGENT BUSINESS MEDIA LTD INTELLIGENT DATA DESIGNS LIMITED INTELLIGENT IP LIMITED INTELLIGENT MONEY ADVICE LIMITED INTELLIGENT REPORTS LTD INTERBLOC FIRE PRODUCTS LIMITED INTER COUNTY DELIVERIES LTD INTERCULTURE CONTACTS LIMITED INTERESTING STRATEGIES LIMITED INTERFIT UK LIMITED INTERGLOBE TRADE & SERVICES LIMITED INTERIOR DESIGN IDEAS LIMITED INTERIOR TILING COMPANY LIMITED INTERIOR WORLD LIMITED INTERLINKS UK LIMITED INTERNATIONAL MANAGEMENT SYSTEMS LIMITED INTERNATIONAL NOISE DOCTOR LIMITED 05514852 05368377 04753661.